Akero Therapeutics (AKRO) had the highest return between August 1, 2022 and October 31, 2022 by a US stock with a market cap of $1B+, returning 306.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Akero Therapeutics (AKRO) | 8/1/2022 - 10/31/2022 | 306.74% |
Enliven Therapeutics (ELVN) | 8/1/2022 - 10/31/2022 | 286.09% |
Immunovant (IMVT) | 8/1/2022 - 10/31/2022 | 176.54% |
Biohaven Pharmaceutical (BHVN) | 8/1/2022 - 10/31/2022 | 176.17% |
89bio (ETNB) | 8/1/2022 - 10/31/2022 | 169.77% |
SS Innovations International Inc Common Stock (SSII) | 8/1/2022 - 10/31/2022 | 161.29% |
Nuvalent (NUVL) | 8/1/2022 - 10/31/2022 | 145.09% |
Verona Pharma PLC ADR (VRNA) | 8/1/2022 - 10/31/2022 | 125.75% |
Diversified Energy (DEC) | 8/1/2022 - 10/31/2022 | 124.44% |
Ardelyx (ARDX) | 8/1/2022 - 10/31/2022 | 117.39% |
YPF Sociedad Anonima (YPF) | 8/1/2022 - 10/31/2022 | 108.74% |
Rhythm Pharmaceuticals (RYTM) | 8/1/2022 - 10/31/2022 | 102.17% |
Genius Sports (GENI) | 8/1/2022 - 10/31/2022 | 101.57% |
Vaxcyte (PCVX) | 8/1/2022 - 10/31/2022 | 91.1% |
Wave Life Sciences (WVE) | 8/1/2022 - 10/31/2022 | 90.08% |
Weatherford International (WFRD) | 8/1/2022 - 10/31/2022 | 84.42% |
Nutanix (NTNX) | 8/1/2022 - 10/31/2022 | 82.79% |
Harrow Health (HROW) | 8/1/2022 - 10/31/2022 | 80.36% |
International Seaways (INSW) | 8/1/2022 - 10/31/2022 | 78.55% |
Torm PLC Class A (TRMD) | 8/1/2022 - 10/31/2022 | 67.55% |
Zeta Global (ZETA) | 8/1/2022 - 10/31/2022 | 62.89% |
Applied Opt (AAOI) | 8/1/2022 - 10/31/2022 | 61.76% |
Calumet Specialty Products Partners (CLMT) | 8/1/2022 - 10/31/2022 | 61.49% |
Expro (XPRO) | 8/1/2022 - 10/31/2022 | 60.97% |
Vertex (VERX) | 8/1/2022 - 10/31/2022 | 60.32% |
